Rui-Rong Xu (Ruirong Xu)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Journal of pain research

Molecular diversity

Medicine

Journal of healthcare engineering

Shandong University of Traditional Chinese Medicine Affiliated Hospital

Tianjin University of Traditional Chinese Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shandong University of Traditional Chinese Medicine Affiliated Hospital

China

Chief Physician/Professor :: Department of Hematology

Shandong University of Traditional Chinese Medicine Affiliated Hospital

China

Associate Chief Physician/Associate Professor

Shandong University of Traditional Chinese Medicine Affiliated Hospital

China

Attending Physician

Yamaguchi Prefecture Central Hospital

Japan

Refresher Physician :: Department of Hematology

Shandong University of Traditional Chinese Medicine Affiliated Hospital

China

Resident Physician

Qingdao West Coast New District Peoples Hospital

China

Resident Physician

Education History

Tianjin University of Traditional Chinese Medicine

China

PHD

Shandong University of Traditional Chinese Medicine

China

BSC

Publications

Chunyi Lyu, Hongyan Xiao, Xuewei Yin, Zonghong Li, Chen Han, Rui-Rong Xu
Acupuncture in Multiple Myeloma Peripheral Neuropathy: A Systematic Review. Journal of pain research 17 (2024)
Chunyi Lyu, Hongyan Xiao, Xuewei Yin, Zonghong Li, Chen Han, Rui-Rong Xu
Acupuncture in Multiple Myeloma Peripheral Neuropathy: A Systematic Review. Journal of pain research 17 (2024)
Lu Sun, Xiaoyang Huang, Juan Wang, Chenglu Yuan, Hongyu Zhao, Daqi Li, Rui-Rong Xu, Yan Wang, Pin Qin, Yan Shi, Jun Peng, Ming Hou, Yu Hou
Eltrombopag plus diacerein vs. eltrombopag in patients with ITP: a multicenter, randomized, open-label, phase 2 trial. Blood (2024)
Xuewei Yin, Chunyi Lyu, Zonghong Li, Qian Wang, Yi Ding, Yan Wang, Yan Qiu, Siyuan Cui, Dadong Guo, Rui-Rong Xu
High Expression of ACOT2 Predicts Worse Overall Survival and Abnormal Lipid Metabolism: A Potential Target for Acute Myeloid Leukemia. Journal of healthcare engineering 2022 (2022)
Chenchen Ma, Peng Liu, Siyuan Cui, Chang Gao, Xing Tan, Zhao-Peng Liu, Rui-Rong Xu
The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside. Molecules (Basel, Switzerland) 27 (18) (2022)
Yuerong Zhao, Siyuan Cui, Yan Wang, Rui-Rong Xu
The Extensive Regulation of MicroRNA in Immune Thrombocytopenia. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 28 (2022)
Xuewei Yin, Zonghong Li, Chunyi Lyu, Yan Wang, Shumin Ding, Chenchen Ma, Jingyi Wang, Siyuan Cui, Jinxin Wang, Dadong Guo, Rui-Rong Xu
Induced effect of zinc oxide nanoparticles on human acute myeloid leukemia cell apoptosis by regulating mitochondrial division. IUBMB life 74 (6) (2022)
Chunyi Lyu, Kui Liu, Yue-Hua Jiang, Teng Wang, Yan Wang, Rui-Rong Xu
Integrated analysis on mRNA microarray and microRNA microarray to screen immune-related biomarkers and pathways in myelodysplastic syndrome. Hematology (Amsterdam, Netherlands) 26 (1) (2021)
Xuewei Yin, Yi Ding, Liming Yu, Chenchen Guo, Yanyan Cui, Xixi Zhai, Yan Wang, Shumin Ding, Mingyue Shen, Zonghong Li, Rui-Rong Xu
Efficacy and safety of chemotherapy combined with different doses of IL-2 maintenance therapies for acute myeloid leukemia: A protocol for a Bayesian network meta-analysis. Medicine 100 (23) (2021)
Teng Wang, Chun-Yi Lyu, Yue-Hua Jiang, Xue-Yan Dong, Yan Wang, Zong-Hong Li, Jin-Xin Wang, Rui-Rong Xu
A drug-biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia. Molecular diversity 25 (4) (2020)

Rui-Rong Xu.css-eqlu8i{font-size:small;padding-left:4px;} (Ruirong Xu)

Publication Activity (10 Years)

Top Topics

Top Venues

Rui-Rong Xu (Ruirong Xu)